Active Pharmaceutical Ingredient API News and Research

RSS

Oragenics announces availability of oral care probiotics for children and adults

Florida-based biopharmaceutical company Oragenics, Inc. has announced that its oral care probiotics for children and adults will be available in Australia and New Zealand through an exclusive agreement with Australian Pharmaceutical Industries, owner of the Priceline pharmacy retail chain, and one of the leading service providers to the pharmacy industry.

3 May 2011

Celanese EVA Performance Polymers, PSI partner to develop drug-eluting devices

Particle Sciences Inc., a leading pharmaceutical CRO, and Celanese EVA Performance Polymers, a leading supplier of ethylene vinyl acetate into pharmaceutical applications, are working together to streamline the development of drug-eluting devices.

29 Apr 2011

Lupin grants Salix exclusive worldwide rights to rifaximin

Salix Pharmaceuticals, Ltd. today announced that as of March 31, 2011 Lupin Ltd. granted Salix exclusive worldwide rights (except for India) to exploit Lupin technology and technology jointly developed by Lupin and Salix for all rifaximin products for human use. This agreement expands the collaboration that Salix and Lupin entered into as of September 30, 2009.

6 Apr 2011

PQM program launches new public medicine database

In the growing global battle against substandard and counterfeit medicines, the Promoting the Quality of Medicines program has launched a new, public database of medicines collected and analyzed in collaboration with stakeholders from countries in Africa, South America and Southeast Asia.

6 Apr 2011

MonoSol Rx receives positive FDA feedback on 505(b)(2) pathway for Montelukast Sodium OSF

MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it held a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of Montelukast Sodium Oral Soluble Film (OSF) under a 505(b)(2) pathway.

30 Mar 2011

Covaris launches Bench-top SF220 Formulation Processing System

Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System.

25 Mar 2011

Medidata fourth quarter net revenue is $47.4 million for 2010

Medidata Solutions, a leading global provider of SaaS-based clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the fourth quarter 2010 and full year ended December 31, 2010, as well as provided financial guidance for the first quarter and full year 2011.

15 Mar 2011

CCCB selects CLC bio's enterprise platform for next generation sequence analysis

After a thorough head-to-head evaluation against various competing solutions, the Center for Cancer Computational Biology at the Dana-Farber Cancer Institute has selected CLC bio's enterprise platform for next generation sequence analysis.

8 Mar 2011

Celerion completes Clean Room, pharmacist certification to comply with USP 797 guidelines

Celerion, the premier provider of innovative early stage drug development solutions, announces the completion of a Clean Room and pharmacist certification to comply with USP 797 guidelines.

3 Mar 2011

USPTO issues patent to Silence Therapeutics' siRNA technology

Silence Therapeutics plc announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office.

23 Feb 2011

Kronos announces additional details regarding pending acquisition of API Healthcare at HIMSS conference

Kronos Incorporated today announced additional details regarding its pending acquisition of API Healthcare Corporation to organizations attending the HIMSS conference being held this week. The closing of the transaction is subject to regulatory approval and customary closing conditions.

22 Feb 2011

Hitachi expands Medical Imaging VNAs to include entire healthcare facility

Hitachi Data Systems Corporation, a wholly owned subsidiary of Hitachi, Ltd., today introduced a new solution for healthcare providers to improve clinical decision making and resulting patient care. Hitachi Clinical Repository (HCR) is an information management solution that transforms raw medical data and images into meaningful information, independent of the source applications.

21 Feb 2011

CARBOGEN AMCIS installs new stability chambers at Switzerland facility

Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has expanded its service portfolio and capacity for stability studies. In compliance with the latest International Conference on Harmonisation (ICH) guidelines, and in response to customer demand, the company has installed new stability chambers at the Hunzenschwil (Neuland), Switzerland operations and offers short-term, long-term, accelerated, intermediate, follow-up and customized tests.

21 Feb 2011

Tianyin Pharmaceutical's second quarter revenue increases 69.6% to $25.3 million

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the second quarter of Fiscal Year 2011.

14 Feb 2011

BioCryst reports net loss of $9.1M for fourth quarter 2010 vs. $15.2M net income for fourth quarter 2009

BioCryst Pharmaceuticals, Inc. announced financial results for the fourth quarter and full year ended December 31, 2010.

10 Feb 2011

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

8 Feb 2011

Teva fourth quarter net sales increase 16% to record $4.4 billion

Teva Pharmaceutical Industries Ltd. today reported results for the quarter and year ended December 31, 2010.

8 Feb 2011

Almac opens analytical facility at new 240,000 sq. ft. North American Headquarters

Almac's new 240,000 sq. ft. North American Headquarters, built on 40 acres in Souderton, PA, north of Philadelphia is part of the Almac Group's integrated services solutions strategy. The new facility delivers full-service, integrated clinical packaging, drug supply management and technology solutions to pharmaceutical and biotech clients.

8 Feb 2011

Kronos to acquire API Healthcare from Francisco

Kronos Incorporated today announced that it has entered into a definitive agreement to acquire API Healthcare Corporation from Francisco Partners. Closing of the transaction is subject to regulatory approval and customary closing conditions.

8 Feb 2011

AMRI fourth quarter total revenue increases 12% to $48.6 million

AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2010.

7 Feb 2011

Active Pharmaceutical Ingredient API News and Research

Oragenics announces availability of oral care probiotics for children and adults

Celanese EVA Performance Polymers, PSI partner to develop drug-eluting devices

Lupin grants Salix exclusive worldwide rights to rifaximin

PQM program launches new public medicine database

MonoSol Rx receives positive FDA feedback on 505(b)(2) pathway for Montelukast Sodium OSF

Covaris launches Bench-top SF220 Formulation Processing System

Medidata fourth quarter net revenue is $47.4 million for 2010

CCCB selects CLC bio's enterprise platform for next generation sequence analysis

Celerion completes Clean Room, pharmacist certification to comply with USP 797 guidelines

USPTO issues patent to Silence Therapeutics' siRNA technology

Kronos announces additional details regarding pending acquisition of API Healthcare at HIMSS conference

Hitachi expands Medical Imaging VNAs to include entire healthcare facility

CARBOGEN AMCIS installs new stability chambers at Switzerland facility

Tianyin Pharmaceutical's second quarter revenue increases 69.6% to $25.3 million

BioCryst reports net loss of $9.1M for fourth quarter 2010 vs. $15.2M net income for fourth quarter 2009

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

Teva fourth quarter net sales increase 16% to record $4.4 billion

Almac opens analytical facility at new 240,000 sq. ft. North American Headquarters

Kronos to acquire API Healthcare from Francisco

AMRI fourth quarter total revenue increases 12% to $48.6 million

Industry Focus - Biopharma eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News